Skip to content

Category: clinical trials

Foundation Fighting Blindness and 4D Molecular Therapeutics Partner to Boost Retinal Gene Therapy Development

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Foundation Fighting Blindness and 4D Molecular Therapeutics Partner to Boost Retinal Gene Therapy Development Promising gene therapies for inherited retinal diseases (IRDs) — many of which have moved into clinical trials — use viral delivery systems (aka vectors)…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

FFB-Funded Scientists Report on Nine Promising Translational Research Efforts

Source: Foundation Fighting Blindness Blog – Eye on the Cure – FFB-Funded Scientists Report on Nine Promising Translational Research Efforts Translational research — moving promising science out of laboratories and into clinical trials — is essential to getting vision-saving, retinal-disease treatments out to the millions who need them. With…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

ID Your IRD: A Free Genetic Testing Program for Eligible People with Inherited Retinal Diseases

Source: Foundation Fighting Blindness Blog – Eye on the Cure – ID Your IRD: A Free Genetic Testing Program for Eligible People with Inherited Retinal Diseases Genes are like the blueprint or code for determining who we are. We all have about 23,000 pairs of genes in most cells…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials

Source: Foundation Fighting Blindness Blog – Eye on the Cure – AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials Company Builds on FFB’s Initial Investment to Garner $265 Million in Therapy Development Funding In the early 1990s, scientists began discovering the genetic defects causing…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest